Bliss GVS Pharma (BLISSGVS.NS)

Executive Summary

Bliss GVS Pharma Limited is an India-based pharmaceutical company with a global footprint, operating in over 75 countries. The company specializes in the development, manufacturing, and marketing of finished formulations, active pharmaceutical ingredients (APIs), and animal health products. It is recognized as the world's largest manufacturer of suppositories and pessaries, serving therapeutic areas such as anti-infectives, pain management, cardiovascular health, and dermatology. The company's integrated business model spans from API synthesis to finished dosage forms, supporting its commercial activities in regulated, semi-regulated, and emerging markets. With manufacturing facilities approved by various international regulatory agencies, Bliss GVS Pharma leverages its own subsidiaries and distributors to reach diverse markets. Its public listing on the National Stock Exchange of India provides transparency and access to capital markets. The company's consistent focus on niche manufacturing and global diversification positions it as a resilient player in the pharmaceutical industry, with potential for steady growth as it expands its product portfolio and market reach.

Upcoming Catalysts (preview)

• TBDUS FDA Approval for New Suppository Product50% success
• Q3 2026Expansion into African Markets via Partnership70% success
• TBDLaunch of New Animal Health Product Line60% success